- Home
- TK vs GHRS Comparison
TK vs GHRS Comparison
Compare TK & GHRS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | TK | GHRS |
|---|---|---|
| Founded | 1973 | 2018 |
| Country | Bermuda | Ireland |
| Employees | N/A | N/A |
| Industry | Marine Transportation | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 937.1M | 947.2M |
| IPO Year | 1995 | 2021 |
Fundamental Metrics
Financial Performance| Metric | TK | GHRS |
|---|---|---|
| Price | $13.36 | $22.07 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 8 |
| Target Price | N/A | ★ $41.38 |
| AVG Volume (30 Days) | ★ 492.0K | 193.2K |
| Earning Date | 05-13-2026 | 05-01-2026 |
| Dividend Yield | ★ 15.21% | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | $13.43 | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $7.12 | $10.96 |
| 52 Week High | $14.38 | $24.66 |
Technical Indicators
Market Signals| Indicator | TK | GHRS |
|---|---|---|
| Relative Strength Index (RSI) | 51.28 | 61.36 |
| Support Level | $12.87 | $12.65 |
| Resistance Level | $13.76 | $22.88 |
| Average True Range (ATR) | 0.56 | 1.49 |
| MACD | -0.05 | -0.13 |
| Stochastic Oscillator | 32.45 | 58.59 |
Price Performance
Historical ComparisonAbout TK Teekay Corporation
Teekay Corp Ltd provides international crude oil marine transportation and other marine services. It also offers offshore oil production, storage, and offloading services, under long-term, fixed-rate contracts. The company has two primary lines of business: Marine services and tankers. It manages these businesses for the benefit of all stakeholders. The company serves energy and utility companies, oil traders, large oil and LNG consumers, petroleum product producers, government agencies, and various other entities that depend upon marine transportation.
About GHRS GH Research PLC
GH Research PLC is a clinical-stage biopharmaceutical company dedicated to transforming the lives of patients by developing a practice-changing treatment for depression. Its initial focus is on developing novel and proprietary mebufotenin therapies for the treatment of patients with Treatment-Resistant Depression, or TRD. Its portfolio currently includes GH001, a proprietary inhalable mebufotenin product candidate, and GH002, a proprietary intravenous mebufotenin product candidate. The group has only a single segment: Research and Development.